Melanoma of the Eye Latest Advances

Comparative Proteomic Profiling of Microdissected Spindle and Epithelioid Uveal Melanoma Subtypes.

Journal: Investigative ophthalmology & visual science

Published: April 15, 2026

HSR26-199: Socioeconomic, Geographic, and Insurance-Related Disparities in Survival and Treatment Outcomes for Ocular Melanoma: A 21-Year National Inpatient Cohort Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

HSR26-203: Financial Burden of Ocular Melanoma: A 7 Year Analysis of Trends Influencing Patient Charges and Costs to Hospitals in the Treatment of Ocular Melanoma.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Association of clinical and morphological tumor characteristics with the status of chromosomes 1, 3, and 8 in iris melanoma

Journal: Vestnik oftalmologii

Published: March 18, 2026

Application of artificial intelligence in pathological diagnosis of ocular tumors

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: March 12, 2026

A Rare Case of Paraneoplastic Raynaud's Phenomenon and Uveal Melanoma.

Journal: Acta dermatovenerologica Croatica : ADC

Published: March 10, 2026

Artificial Intelligence in Ocular Surface Tumors: Current Advances, Challenges, and Future Directions.

Journal: Diagnostics (Basel, Switzerland)

Published: February 20, 2026

Acral Lentiginous Melanoma With NRAS Mutation and Ocular Surface Toxicity Following Immunotherapy and Investigational KRASG12C Inhibitor: Case Report.

Journal: Case reports in oncological medicine

Published: February 18, 2026

Dihydroartemisinin Induces Ferroptosis in Uveal Melanoma Cells Through the HO-1 and xCT/GPX4 Signaling Pathways.

Journal: International journal of molecular sciences

Published: February 12, 2026

MTG2 as a Causal and Druggable Target in Uveal Melanoma via Mitochondrial DNA Dynamics: Evidence From Functional Validation and DMSA Identification.

Journal: Investigative ophthalmology & visual science

Published: February 12, 2026

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Journal: Journal for immunotherapy of cancer

Published: February 10, 2026

Modeled Aqueous Humor Protein Concentrations to Enable Biomarker Development in Uveal Melanoma.

Journal: International journal of molecular sciences

Published: February 09, 2026

Melanoma of the Eye Latest Advances

Find the Latest Research About Melanoma of the Eye

Comparative Proteomic Profiling of Microdissected Spindle and Epithelioid Uveal Melanoma Subtypes.

Comparative Proteomic Profiling of Microdissected Spindle and Epithelioid Uveal Melanoma Subtypes.

HSR26-199: Socioeconomic, Geographic, and Insurance-Related Disparities in Survival and Treatment Outcomes for Ocular Melanoma: A 21-Year National Inpatient Cohort Study.

HSR26-199: Socioeconomic, Geographic, and Insurance-Related Disparities in Survival and Treatment Outcomes for Ocular Melanoma: A 21-Year National Inpatient Cohort Study.

HSR26-203: Financial Burden of Ocular Melanoma: A 7 Year Analysis of Trends Influencing Patient Charges and Costs to Hospitals in the Treatment of Ocular Melanoma.

HSR26-203: Financial Burden of Ocular Melanoma: A 7 Year Analysis of Trends Influencing Patient Charges and Costs to Hospitals in the Treatment of Ocular Melanoma.

Association of clinical and morphological tumor characteristics with the status of chromosomes 1, 3, and 8 in iris melanoma

Association of clinical and morphological tumor characteristics with the status of chromosomes 1, 3, and 8 in iris melanoma

Application of artificial intelligence in pathological diagnosis of ocular tumors

Application of artificial intelligence in pathological diagnosis of ocular tumors

A Rare Case of Paraneoplastic Raynaud's Phenomenon and Uveal Melanoma.

A Rare Case of Paraneoplastic Raynaud's Phenomenon and Uveal Melanoma.

Artificial Intelligence in Ocular Surface Tumors: Current Advances, Challenges, and Future Directions.

Artificial Intelligence in Ocular Surface Tumors: Current Advances, Challenges, and Future Directions.

Acral Lentiginous Melanoma With NRAS Mutation and Ocular Surface Toxicity Following Immunotherapy and Investigational KRASG12C Inhibitor: Case Report.

Acral Lentiginous Melanoma With NRAS Mutation and Ocular Surface Toxicity Following Immunotherapy and Investigational KRASG12C Inhibitor: Case Report.

Dihydroartemisinin Induces Ferroptosis in Uveal Melanoma Cells Through the HO-1 and xCT/GPX4 Signaling Pathways.

Dihydroartemisinin Induces Ferroptosis in Uveal Melanoma Cells Through the HO-1 and xCT/GPX4 Signaling Pathways.

MTG2 as a Causal and Druggable Target in Uveal Melanoma via Mitochondrial DNA Dynamics: Evidence From Functional Validation and DMSA Identification.

MTG2 as a Causal and Druggable Target in Uveal Melanoma via Mitochondrial DNA Dynamics: Evidence From Functional Validation and DMSA Identification.

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Modeled Aqueous Humor Protein Concentrations to Enable Biomarker Development in Uveal Melanoma.

Modeled Aqueous Humor Protein Concentrations to Enable Biomarker Development in Uveal Melanoma.